AIG-01

N/A

Report date: 2026/03/11 20:02:12

NME

Base Information

Drug NameAIG-01

Drug Alias NameAIG-01AIG01

ClassificationOther

Mechanisms of ActionSon of sevenless homolog 1 inhibitors

TargetsSon of sevenless homolog 1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsCarcinoma, Pancreatic Ductal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAIGEN Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsCarcinoma, Pancreatic Ductal

Inactive IndicationsN/A

ATC CodeN/A